Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company DuecomplusA AB
DescriptionSaponin fractions of Quillaja saponaria Molina
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationAcute myelogenous leukemia (AML)
Indication DetailsTreat acute myelogenous leukemia (AML)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today